Kuala Lumpur - Delayed Quote MYR

PeterLabs Holdings Berhad (0171.KL)

0.3550
+0.0200
+(5.97%)
As of 10:20:04 AM GMT+8. Market Open.
Loading Chart for 0171.KL
  • Previous Close 0.3350
  • Open 0.3300
  • Bid 0.3500 x --
  • Ask 0.3550 x --
  • Day's Range 0.3250 - 0.3550
  • 52 Week Range 0.1700 - 0.3550
  • Volume 1,073,600
  • Avg. Volume 2,296,791
  • Market Cap (intraday) 97.701M
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 35.50
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield 0.00 (2.22%)
  • Ex-Dividend Date Mar 21, 2024
  • 1y Target Est --

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally. The company operates in Manufacturing and Trading segments. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements. The company markets its animal feed additives under the OsmoFAT brand. It engages in the distribution of consumer goods, including home care, oral care, baby care, and feminine care products, as well as infant and growing up milk powder and grain products to retailers, such as supermarkets, mini markets, sundry shops, convenience stores, pharmacies, petrol kiosks, Chinese medical halls, and hardware stores. The company was founded in 2002 and is headquartered in Nilai, Malaysia.

www.peterlabs.com.my

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0171.KL

View More

Performance Overview: 0171.KL

Trailing total returns as of 5/26/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .

YTD Return

0171.KL
86.84%
FTSE Bursa Malaysia KLCI (^KLSE)
6.66%

1-Year Return

0171.KL
69.05%
FTSE Bursa Malaysia KLCI (^KLSE)
5.33%

3-Year Return

0171.KL
91.42%
FTSE Bursa Malaysia KLCI (^KLSE)
0.53%

5-Year Return

0171.KL
122.18%
FTSE Bursa Malaysia KLCI (^KLSE)
6.70%

Compare To: 0171.KL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0171.KL

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    92.20M

  • Enterprise Value

    97.21M

  • Trailing P/E

    32.52

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    1.16

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    20.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.61%

  • Return on Assets (ttm)

    2.47%

  • Return on Equity (ttm)

    3.86%

  • Revenue (ttm)

    176.03M

  • Net Income Avi to Common (ttm)

    2.84M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.65M

  • Total Debt/Equity (mrq)

    22.65%

  • Levered Free Cash Flow (ttm)

    -67.64k

Research Analysis: 0171.KL

View More

Company Insights: 0171.KL

Research Reports: 0171.KL

View More

People Also Watch